Allergic Rhinitis: Glenmark's Ryaltris nasal spray approved in Europe for treatment in over 12 years of age newstracklive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newstracklive.com Daily Mail and Mail on Sunday newspapers.
Will soon launch nasal spray Ryaltris in EU, says Glenmark
By IANS |
7 Views
Glenmark and Bausch Health to commercialize Ryaltris nasal spray in Canada.. Image Source: IANS News
Chennai, April 26 : Pharma major Glenmark Pharmaceuticals Ltd on Monday said it is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray Ryaltris across the European Union.
The company said Ryaltris (olopatadine hydrochloride 665 mcg and mometasone furoate 25 mcg), will shortly be available in Austria, Belgium, the Czech Republic, Germany, Denmark, Spain, Finland, France, Ireland, Italy, The Netherlands, Norway, Poland, Romania, Slovakia, Sweden, as well as the UK.